Pegasus Partners’s Exelixis EXEL Stock Holding History

Pegasus Partners’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-68,751	Closed	-$1.64M	–	173
2019 Q1	$1.64M	Buy	+68,751	New	+$1.57M	0.48%	78

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Pegasus Partners's EXEL Position: Q2 2019 in Review

Pegasus Partners sold out of Exelixis (EXEL) in Q2 2019, closing a stake of 68,751 shares — an estimated $1.64M sold.

Pegasus Partners first reported a position in EXEL in Q1 2019 and held it in 1 quarter. The position peaked at $1.64M in Q1 2019. 346 funds tracked by Wall St. Rank hold EXEL as of Q2 2019.

Pegasus Partners reported no remaining Exelixis position as of Q2 2019 after selling out during the quarter.
Pegasus Partners sold 68,751 Exelixis shares in Q2 2019, an estimated $1.64M.
Pegasus Partners first reported a position in Exelixis in Q1 2019 and held it in 1 quarter.
Pegasus Partners's Exelixis position peaked at $1.64M in Q1 2019.
346 funds tracked by Wall St. Rank held Exelixis as of Q2 2019.

Based on Pegasus Partners's 13F filing for Q2 2019, filed 30 Jul 2019.